Integrated Diagnostics (UK) Price Prediction
| IDHC Stock | 0.45 0.02 4.65% |
Oversold Vs Overbought
54
Oversold | Overbought |
Quarterly Earnings Growth 1.229 | EPS Estimate Current Year 1.3905 | EPS Estimate Next Year 1.7727 | Wall Street Target Price 0.544 | Quarterly Revenue Growth 0.387 |
Using Integrated Diagnostics hype-based prediction, you can estimate the value of Integrated Diagnostics Holdings from the perspective of Integrated Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Integrated Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Integrated because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Integrated Diagnostics after-hype prediction price | USD 0.44 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Integrated |
Integrated Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of Integrated Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Integrated Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Integrated Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Integrated Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Integrated Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Integrated Diagnostics' historical news coverage. Integrated Diagnostics' after-hype downside and upside margins for the prediction period are 0.02 and 4.25, respectively. We have considered Integrated Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Integrated Diagnostics is abnormally volatile at this time. Analysis and calculation of next after-hype price of Integrated Diagnostics is based on 3 months time horizon.
Integrated Diagnostics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Integrated Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Integrated Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Integrated Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.45 | 3.81 | 0.01 | 0.10 | 3 Events / Month | 1 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.45 | 0.44 | 2.22 |
|
Integrated Diagnostics Hype Timeline
Integrated Diagnostics is currently traded for 0.45on London Exchange of UK. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.1. Integrated is projected to decline in value after the next headline, with the price expected to drop to 0.44. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -2.22%, whereas the daily expected return is currently at 0.45%. The volatility of related hype on Integrated Diagnostics is about 1684.24%, with the expected price after the next announcement by competition of 0.35. About 34.0% of the company shares are held by company insiders. The book value of Integrated Diagnostics was currently reported as 4.64. The company last dividend was issued on the 16th of June 2022. Integrated Diagnostics had 4:1 split on the 24th of December 2020. Assuming the 90 days trading horizon the next projected press release will be in about 3 days. Check out Integrated Diagnostics Basic Forecasting Models to cross-verify your projections.Integrated Diagnostics Related Hype Analysis
Having access to credible news sources related to Integrated Diagnostics' direct competition is more important than ever and may enhance your ability to predict Integrated Diagnostics' future price movements. Getting to know how Integrated Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Integrated Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SYME | SupplyMe Capital PLC | 0.00 | 2 per month | 0.00 | (0.01) | 33.33 | (25.00) | 58.33 | |
| LLOY | Lloyds Banking Group | (0.18) | 3 per month | 0.00 | (0.08) | 2.37 | (2.67) | 9.67 | |
| PREM | Premier African Minerals | 0.01 | 1 per month | 7.96 | 0.04 | 15.38 | (9.46) | 70.70 | |
| SANB | SANTANDER UK 8 | (0.77) | 4 per month | 0.00 | (0.10) | 0.37 | (0.37) | 1.47 | |
| 88E | 88 Energy | 0.00 | 1 per month | 0.00 | (0.12) | 2.70 | (2.78) | 8.12 | |
| 0LQQ | Vodafone Group PLC | (0.30) | 2 per month | 0.00 | (0.19) | 2.07 | (1.54) | 11.69 | |
| VOD | Vodafone Group PLC | (0.34) | 1 per month | 0.00 | (0.14) | 1.74 | (1.89) | 10.62 |
Integrated Diagnostics Additional Predictive Modules
Most predictive techniques to examine Integrated price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Integrated using various technical indicators. When you analyze Integrated charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Integrated Diagnostics Predictive Indicators
The successful prediction of Integrated Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Integrated Diagnostics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Integrated Diagnostics based on analysis of Integrated Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Integrated Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Integrated Diagnostics's related companies.
Story Coverage note for Integrated Diagnostics
The number of cover stories for Integrated Diagnostics depends on current market conditions and Integrated Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Integrated Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Integrated Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Integrated Diagnostics Short Properties
Integrated Diagnostics' future price predictability will typically decrease when Integrated Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Integrated Diagnostics Holdings often depends not only on the future outlook of the potential Integrated Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Integrated Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 600 M | |
| Cash And Short Term Investments | 860.5 M |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.